Walder Wyss advised the founders of DT Swiss, as they have completed a succession solution for one of the founders, combined with the expansion of the shareholder base to include members of the DT Swiss
Tags :Walder Wyss
Givaudan made an equity investment and entered a strategic collaboration with Microcaps. In connection with the operation, Walder Wyss advised Microcaps, while Homburger represented Givaudan. The parties Givaudan is a globally active specialist in fragrance
Walder Wyss advised Glarner Kantonalbank on the issuance of CHF 125 million tier 2 bonds with a 1.55% coupon at an issue price of 100.048%. The bonds have a ten-year term to 2 July 2036 and are callable after five years.
Siegfried Holding, a Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry, entered into a CHF 650 m term and revolving facilities agreement, with UBS Switzerland acting as mandated lead arranger, coordinator and agent. In
Walder Wyss advised CABB Group on its issuance of EUR 625 million 8.00% senior secured notes due 2031. CABB Group, which is owned by Permira funds, is a Crop Science contract development and manufacturing organization (CDMO), supplying customised
Walder Wyss advised CeQur, a Swiss medical device company specialising in insulin-delivery solutions, throughout closing of a USD 100 million Series E equity financing. CeQur intends to use the funds to further accelerate growth across its
Walder Wyss advised funds managed by Pharmakon Advisors — an investor in non-dilutive debt for the life sciences industry and the investment manager of the BioPharma Credit funds — in connection with their role as investors in
Walder Wyss acted as Swiss legal advisor to Veraxa Biotech in its business combination with Voyager Acquisition Corp., resulting in a listing on the NASDAQ Stock Market under ticker symbols VRXA and VRXAW.
Walder Wyss advised the shareholders of Ferax Treuhand as the state-supervised fiduciary and audit firm based in Zurich, and focused on audit services for the insurance sector has entered into a strategic partnership with Trusso
Walder Wyss advised Helvetia Baloise on its inaugural senior bond issuance following the merger of Helvetia and Baloise, placing three tranches in an aggregate amount of CHF 550 million on the Swiss capital market. The proceeds
